5th Antigen Specific Immune Tolerance Digital Summit
Evvnt Promotion / evvnt
Archivio
26.01.2022 - 27.01.2022Online, USA
Time: 08:00 - 17:30
Temi della conferenza Molecular mechanisms underlying tolerance induction remain to be elucidated and some clinical setbacks have highlighted the need to lean into the translational challenges the space is facing.
Speakers: Poul Sorensen Professor, Chief Scientific Officer and Co-Founder Allero Therapeutics, Rupert Sandbrink Chief Executive Officer Cellerys and more.